{"id":8551,"date":"2023-10-27T19:18:32","date_gmt":"2023-10-27T23:18:32","guid":{"rendered":"https:\/\/www.bluerocktx.com\/?p=8551"},"modified":"2024-01-23T13:13:15","modified_gmt":"2024-01-23T18:13:15","slug":"just-one-question-podcast-s3-e6-biotech-expert-seth-and-nick-discuss-revolutionary-regenerative-medicine-treatments","status":"publish","type":"post","link":"https:\/\/www.bluerocktx.com\/just-one-question-podcast-s3-e6-biotech-expert-seth-and-nick-discuss-revolutionary-regenerative-medicine-treatments\/","title":{"rendered":"Just One Question Podcast: S3 E6 – Biotech expert Seth and Nick discuss revolutionary regenerative medicine treatments"},"content":{"rendered":"
Seth Ettenberg and Nick discuss how technology is used to develop regenerative medicine for conditions such as Parkinson’s disease and Alzheimer’s disease.<\/p>\n
Seth Ettenberg is CEO and President of BlueRock Therapeutics, a wholly owned subsidiary of Bayer. He\u2019s a biotech entrepreneur, on the cutting edge of something called regenerative medicine.<\/p>\n